Guardant Health AMEA and Genconn Biotech announced today a collaboration to market Guardant Health’s liquid biopsy, Guardant360^®, in Taiwan. The Guardant360^® Launch Symposium, held at the Sheraton Grand Taipei Hotel, is targeted at addressing the growing cancer burden in Taiwan which has risen to approximately 49,000 cancer deaths in 2018 according to the statistics provided by Taiwan’s Ministry of Health and Welfare.